rituximab/cyclophosphamide/vincristine (Oncocin)/prednisone (R-CVP)

Introduction

A chemotherapy regimen for treatment of lymphomas.

Dosage

• six 21-day cycles
  • rituximab (375 mg/m2) administered on day 1 of each cycle
  • on days 1-5
    • cyclophosphamide (400 mg/m2)
    • vincristine (1 mg capped dose)
    • prednisone (40 mg/m2)

More general terms

• antineoplastic combination (combination chemotherapy)

Components

• rituximab (Rituxan, Mabthera, Truxima, Ruxience, Riabni)
• vincristine; 22-oxovincaleukoblastine; leurocristine (Oncovin, Vincasar PFS)
• cyclophosphamide (Cytoxan, Neosar, Procytox {Canadian}) [CPM, CTX, CYT, NSC 26271]
• prednisone (Deltasone, Orasone, Liquid Pred, Meticortin, Rayos)